Forgot your password?

Forgot your username?

database > company
Seegene, Inc.
9700 Great Seneca Highway
Rockville, MD 20850 USA
phone:301 762 9066
fax:
Symbol
Exchange
Founded 0
Employees
www.seegene.com
Research Sector
Summary Description
Management
Ownership
Financials


* numbers in thousands
 
Keywords
PCR, viral detection, j2008

Comment | Printable Version | Modify profile |
Updated: Apr. 12, 2011

Description
Founded in 2000, Seegene, Inc, has brought a new dimension to PCR which is the core tool in microbiology. We have developed the innovative technologies, ACP (Annealing Control Primer)TM and DPO (Dual Specific Oligonucleotide)TM which maximize the sensitivity and specificity of PCR. These breakthrough technologies have been applied in various fields of genomic research and yielded significant achievements.
Products / Services
Seeplex? is a breakthrough multiplexing PCR technology that enables a new standard in simultaneous multi-pathogen detection. Seegene applies its novel and proprietary Seeplex? system utilizing "DPO" (Dual Priming Oligo)" to create multi-pathogen tests delivering maximum specificity, reproducibility and sensitivity. Seeplex can be applied to broad range of molecular diagnostics area including human, animal, plant, and microorganism.
Technology / Differentiation
Seegene specializes in oligo technologies and has two core oligo platform named "ACP" (Annealing Control Primer) and "DPO" (Dual Priming Oligonucleotide). The technologies are covered by an extended portfolio of international patents. Many of them are available for OEM & licensing. The internal developments are the technological basis for Seegene's growing range of innovative products for in vitro diagnostics in the laboratory.


2012-05-14-554